Waddell & Reed Financial’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | $12.6M | Sell |
168,640
-941,262
| -85% | -$70.2M | 0.03% | 389 |
|
2020
Q4 | $189M | Sell |
1,109,902
-19,088
| -2% | -$3.25M | 0.4% | 61 |
|
2020
Q3 | $159M | Sell |
1,128,990
-2,443
| -0.2% | -$343K | 0.38% | 60 |
|
2020
Q2 | $181M | Sell |
1,131,433
-870
| -0.1% | -$139K | 0.47% | 51 |
|
2020
Q1 | $111M | Sell |
1,132,303
-3,668
| -0.3% | -$359K | 0.36% | 75 |
|
2019
Q4 | $147M | Sell |
1,135,971
-51,155
| -4% | -$6.6M | 0.36% | 68 |
|
2019
Q3 | $89.4M | Buy |
1,187,126
+131,544
| +12% | +$9.91M | 0.23% | 124 |
|
2019
Q2 | $160M | Buy |
1,055,582
+723
| +0.1% | +$110K | 0.4% | 65 |
|
2019
Q1 | $126M | Sell |
1,054,859
-129,286
| -11% | -$15.4M | 0.31% | 85 |
|
2018
Q4 | $129M | Buy |
1,184,145
+240,510
| +25% | +$26.2M | 0.37% | 64 |
|
2018
Q3 | $152M | Buy |
943,635
+159,235
| +20% | +$25.7M | 0.34% | 83 |
|
2018
Q2 | $104M | Buy |
+784,400
| New | +$104M | 0.24% | 119 |
|